Gobbi, Gabriella

7 records totalling $3,165,547.00 CAD, from official Government of Canada open data.

Embed this chart

By department

Canadian Institutes of Health Research $3,165,547 7 records

Records

Gobbi, Gabriella $784,126.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
FY 2020-2021
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...

Gobbi, Gabriella $684,675.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
FY 2026-2027
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commerc...

GOBBI, Gabriella $527,746.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2013-2014
Canada

Melatonin MT1 receptor as a target for antidepressant drugs

Gobbi, Gabriella $459,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2017-2018
Canada

Analgesic mechanisms of melatonin MT2 receptor ligands.

Gobbi, Gabriella $450,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
FY 2025-2026
Canada

The specific objective of this funding opportunity is to: • Enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on com...

Gobbi, Gabriella $160,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2016-2017
Canada

Novel first-in-class MT2 melatonin receptor partial agonists for neuropathic pain

Gobbi, Gabriella $100,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2016-2017
Canada

Adolescent cannabis consumption and risk of depression. An evidence-based approach